B.J.C. van den Bosch

1.5k citations

29 papers · 1.1k indexed · 1 hit paper · h-index 14

Co-authors: Marinus J. Blok Aimée Paulussen Rick Kamps Sofia Xanthoulea Andrea Romano Rita D. Brandão Hubert J.M. Smeets I.F.M. de Coo
Topics: Mitochondrial Function and Pathology (12 papers)ATP Synthase and ATPases Research (8 papers)Metabolism and Genetic Disorders (6 papers)
Cited by: Clinical Biochemistry Immunology and Allergy Cancer Research
Journals: Nucleic Acids Research PLoS ONE Brain
Partner nations: Netherlands Germany France

In The Last Decade

B.J.C. van den Bosch

27 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification

2017 321 citations Rick Kamps, B.J.C. van den Bosch et al. profile →

Peers

Countries citing papers authored by B.J.C. van den Bosch

Since Specialization

Citations

This map shows the geographic impact of B.J.C. van den Bosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.J.C. van den Bosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.J.C. van den Bosch more than expected).

Fields of papers citing papers by B.J.C. van den Bosch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.J.C. van den Bosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.J.C. van den Bosch. The network helps show where B.J.C. van den Bosch may publish in the future.

Co-authorship network of co-authors of B.J.C. van den Bosch

This figure shows the co-authorship network connecting the top 25 collaborators of B.J.C. van den Bosch. A scholar is included among the top collaborators of B.J.C. van den Bosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.J.C. van den Bosch. B.J.C. van den Bosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation 2025 ·Clinical and Translational Science ·(unknown),Maja Matić,Arwin Ralf,B.J.C. van den Bosch,Manfred Kayser,(unknown),Melvin Lafeber,Marieke J. H. Coenen,Florence Atrafi	0
2	Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency 2023 ·Metabolites ·(unknown),Luc J. J. Derijks,B.J.C. van den Bosch,(unknown),(unknown),Adriaan A. van Bodegraven,Dennis R. Wong	0
3	Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity 2021 ·Journal of Oncology Pharmacy Practice ·Charlotte W. Ockeloen,(unknown),(unknown),Jörgen Bierau,Judith de Vos‐Geelen,Annelieke E.C.A.B. Willemsen,B.J.C. van den Bosch,Marieke J. H. Coenen	4
4	Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time 2018 ·Current Therapeutic Research ·Marieke J. H. Coenen,Aimée Paulussen,(unknown),Martijn Lindhout,Demis Tserpelis,Anja Steyls,Jörgen Bierau,B.J.C. van den Bosch	10
5	Genetic defects in mtDNA-encoded protein translation cause pediatric, mitochondrial cardiomyopathy with early-onset brain disease 2018 ·European Journal of Human Genetics ·Rick Kamps,Radek Szklarczyk,Tom E. J. Theunissen,Debby M.E.I. Hellebrekers,Suzanne C.E.H. Sallevelt,(unknown),Bart de Koning,B.J.C. van den Bosch,Gajja S. Salomons,(unknown),Robert M. Verdijk,Kees Schoonderwoerd,I.F.M. de Coo,Jo Vanoevelen,Hubert J.M. Smeets	22
6	Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV 2018 ·PLoS ONE ·(unknown),Jörgen Bierau,Jaap Bakker,(unknown),(unknown),Aimée Paulussen,B.J.C. van den Bosch,Mathie P.G. Leers,Bettina E. Hansen,Annelies Verbon	5
7	Rapid Resolution of Blended or Composite Multigenic Disease in Infants by Whole-Exome Sequencing 2017 ·The Journal of Pediatrics ·Tom E. J. Theunissen,Suzanne C.E.H. Sallevelt,Debby M.E.I. Hellebrekers,Bart de Koning,Alexandra T.M. Hendrickx,B.J.C. van den Bosch,Rick Kamps,Kees Schoonderwoerd,Radek Szklarczyk,(unknown),I.F.M. de Coo,Hubert J.M. Smeets	6
8	Differences in Strength and Timing of the mtDNA Bottleneck between Zebrafish Germline and Non-germline Cells 2016 ·Cell Reports ·Auke B.C. Otten,Tom E. J. Theunissen,Josien G. Derhaag,(unknown),(unknown),Marie Winandy,Aafke P.A. van Montfoort,Katsiaryna Tarbashevich,Erez Raz,Mike Gerards,Jo Vanoevelen,B.J.C. van den Bosch,Marc Müller,Hubert J.M. Smeets	41
9	Two Novel Mutations in the SLC25A4 Gene in a Patient with Mitochondrial Myopathy 2015 ·JIMD Reports ·(unknown),Marjolein Visser,H. D. Bakker,Ronald J. A. Wanders,Fleur Vansenne,H.R. Scholte,L. Dorland,Gerry A. F. Nicolaes,(unknown),Hubert J.M. Smeets,Alexandra T.M. Hendrickx,B.J.C. van den Bosch	25
10	Defective NDUFA9 as a novel cause of neonatally fatal complex I disease 2011 ·Journal of Medical Genetics ·B.J.C. van den Bosch,Mike Gerards,Wim J. Sluiter,Alexander P.A. Stegmann,(unknown),Debby M.E.I. Hellebrekers,Renske Oegema,(unknown),Holger Prokisch,Katharina Danhauser,Kees Schoonderwoerd,I.F.M. de Coo,Hubert J.M. Smeets	46
11	Large scale mtDNA sequencing reveals sequence and functional conservation as major determinants of homoplasmic mtDNA variant distribution 2011 ·Mitochondrion ·A.M. Voets,B.J.C. van den Bosch,Alphons P. M. Stassen,Alexandra T.M. Hendrickx,Debby M.E.I. Hellebrekers,L. Van Laer,Els Van Eyken,Guy Van Camp,Angela Pyle,Simon Baudouin,Patrick F. Chinnery,Hubert J.M. Smeets	6
12	Defective complex I assembly due to C20orf7 mutations as a new cause of Leigh syndrome 2009 ·Journal of Medical Genetics ·Mike Gerards,Wim J. Sluiter,B.J.C. van den Bosch,L. Elly A. de Wit,(unknown),(unknown),(unknown),Kees Schoonderwoerd,H.R. Scholte,R. J. E. Jongbloed,Alexandra T.M. Hendrickx,I.F.M. de Coo,Hubert J.M. Smeets	59
13	The unfolding clinical spectrum of POLG mutations 2009 ·Journal of Medical Genetics ·Marinus J. Blok,B.J.C. van den Bosch,(unknown),Alexandra T.M. Hendrickx,C E de Die-Smulders,Jessica E. Hoogendijk,Esther Brusse,Marjolein Visser,Bwee Tien Poll‐The,Jörgen Bierau,I.F.M. de Coo,(unknown)	61
14	Altered myocardial gene expression reveals possible maladaptive processes in heterozygous and homozygous cardiac myosin-binding protein C knockout mice 2007 ·Genomics ·Lars Eijssen,B.J.C. van den Bosch,Nicolas Vignier,Patrick Lindsey,(unknown),Lucie Carrier,Pieter A. Doevendans,Ger J. Vusse,Hubert J.M. Smeets	11
15	Cardiac Involvement in Adults With m.3243A>G MELAS Gene Mutation 2006 ·The American Journal of Cardiology ·(unknown),I.F.M. de Coo,Osama Soliman,Folkert J. ten Cate,Robert‐Jan van Geuns,Wim B. Vletter,Kees Schoonderwoerd,B.J.C. van den Bosch,Hubert J.M. Smeets,Marcel L. Geleijnse	56
16	Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice 2006 ·Genomics ·B.J.C. van den Bosch,Patrick Lindsey,(unknown),(unknown),Daniel J. Lips,Ger J. Vusse,Torik Ayoubi,Pieter A. Doevendans,H.J.M. Smeets	39
17	Increased risk for cardiorespiratory failure associated with the A3302G mutation in the mitochondrial DNA encoded tRNALeu(UUR) gene 2004 ·Neuromuscular Disorders ·B.J.C. van den Bosch,I.F.M. de Coo,Alexandra T.M. Hendrickx,H. F. M. Busch,G. de Jong,H.R. Scholte,Hubert J.M. Smeets	19
18	Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation 2000 ·Kidney International ·(unknown),Laurence Heidet,Erika Timmer,B.J.C. van den Bosch,Anu Leinonen,Corinne Antignac,J. Ashley Jefferson,Alexander P. Maxwell,L.A.H. Monnens,(unknown),Hubert J.M. Smeets	104
19	Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation 2000 ·Kidney International ·(unknown),Laurence Heidet,Erika Timmer,B.J.C. van den Bosch,Anu Leinonen,Corinne Antignac,J. Ashley Jefferson,Alexander P. Maxwell,L.A.H. Monnens,Cornelis H. Schröder,Hubert J.M. Smeets	1
20	Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography 2000 ·Nucleic Acids Research ·B.J.C. van den Bosch	86

About B.J.C. van den Bosch

B.J.C. van den Bosch is a scholar working on Clinical Biochemistry, Genetics and Transplantation, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (12 papers), ATP Synthase and ATPases Research (8 papers) and Metabolism and Genetic Disorders (6 papers). The work is most often cited by research in Clinical Biochemistry (279 citations), Immunology and Allergy (78 citations) and Cancer Research (186 citations). B.J.C. van den Bosch has collaborated with scholars based in Netherlands, Germany and France. Frequent co-authors include Marinus J. Blok, Aimée Paulussen, Rick Kamps, Sofia Xanthoulea, Andrea Romano, Rita D. Brandão, Hubert J.M. Smeets, I.F.M. de Coo, Mike Gerards and Alexandra T.M. Hendrickx. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact